Back to Journals » ClinicoEconomics and Outcomes Research » Volume 14

Healthcare Resource Utilization and Associated Costs in New Users of Empagliflozin versus DPP-4 Inhibitors and GLP-1 Agonists: A Comparative Analysis Based on Retrospective Real-World Data from German Sickness Funds

Total article views   HTML views PDF downloads Totals
6,826 Dovepress* 6,380+ 444 6,824
PubMed Central* 446 100 546
Totals 6,826 544 7,370
*Since 2 May 2022
Total mentioned Facebook Delicious Reddit Twitter Others
6 0 0 0 2 4

View citations on PubMed Central and Google Scholar